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A B S T R A C T
Background: Accurate fall screening tools are needed to identify those multiple sclerosis (MS) patients at high
risk of falling. The present study aimed at determining the validity of a series of performance-based measures
(PBMs) of lower extremity functions and patient-reported outcomes (PROs) in predicting falls in a sample of MS
patients (n = 84), who were ambulatory independent.
Methods: Patients were assessed using the following PBMs: timed up and go (TUG), timed 25-foot walk (T25FW),
cognitive T25FW, 2-min walk (2MW), and cognitive 2MW. Moreover, a series of valid and reliable PROs were
filled in by participants including the activities-specific balance confidence (ABC), 12-item multiple sclerosis
walking scale (MSWS-12), fall efficacy scale international (FES-I), and modified fatigue impact scale (MFIS). The
dual task cost (DTC) of 2MW and T25FW tests were calculated as a percentage of change in parameters from
single to dual task conditions. Participants were classified as none-fallers and fallers (⩾1) based on their pro-
spective fall occurrence.
Results: In the present study, 41(49%) participants recorded ≥ 1 fall and were classified as fallers. The results of
logistic regression analysis revealed that each individual test, except DTC of 2MW and T25FW, significantly
predicted future falls. However, considering the area under the curves (AUCs), PROs were more accurate
compared to PBMs. In addition, the results of multiple logistic regression with the first two factors extracted from
principal component analysis revealed that both factor 1 (PROs) and factor 2 (PBMs) significantly predicted falls
with a greater odds ratio (OR) for factor 1 (factor 1: P =<0.0001, OR = 63.41 (6.72–597.90)) than factor 2
(P< 0.05, OR = 5.03 (1.33–18.99)).
Conclusions: The results of this study can be used by clinicians to identify and monitor potential fallers in MS
patients.
1. Introduction
Difficulty in walking is a major feature of multiple sclerosis (MS)
(Bethoux and Bennett, 2011). Up to 85% of patients report mobility
impairments, while gait is perceived as the most important bodily
function by MS patients across the disability spectrum (Bethoux and
Bennett, 2011; Heesen et al., 2008). Equally important, the majority of
falls (> 60%) occur during dynamic everyday activities such as walking
and transfers (Sosnoff et al., 2011). Hence, comprehensive assessment
of walking impairments is required to identify those MS patients at high
risk of falls and future comorbidities.
Falling is a significant concern for this group, with studies demon-
strating that more than 50% of patients with MS have a history of at
least 1 fall over a 6-month period (Gianni et al., 2014; Gunn et al.,
2013b). The physical impacts of falls can cause activity limitations and
may have significant effects on patient's participation in the society
(Coote et al., 2014; Gunn et al., 2013b). The number of studies focusing
on falls in patients with MS is low compared to studies on falls in older
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adults (Coote et al., 2014). The results of 2 meta-analyses that focused
on risk factors for falls in patients with MS revealed that cognitive
impairments, balance deficits, progressive type of MS, and use of mo-
bility aids are associated with future falls (Gianni et al., 2014; Gunn
et al., 2013b). Although previous investigations have provided im-
portant information regarding fall predictors in patients with MS, there
is still limited information regarding any associations between walking
impairments and future falls (Gianni et al., 2014; Gunn et al., 2013a,
2013b; Kasser et al., 2011; Nilsagard et al., 2009). To date, the limited
prospective studies have not reached consistent conclusions about the
predictive values of clinical gait measures for future falls (Gunn et al.,
2013a; Nilsagard et al., 2009). For instance, in one prospective study,
the timed up and go (TUG) test combined with a cognitive dual task was
able to identify MS fallers, while in another study the 10-meter walk
test with a cognitive dual task was not predictive of future falls (Gunn
et al., 2013a; Nilsagard et al., 2009). Thus, further prospective studies
are required for developing more accurate tools to screen fall risk levels
among ambulatory MS patients.
Many instruments have been used to evaluate walking impairments
in patients with MS, and they are generally classified as follow: la-
boratory-based measures (spatiotemporal gait characteristics); perfor-
mance-based measures (PBMs) (eg, timed 25-foot walk (T25FW); 2-min
walk (2MW)) and patient-reported outcomes (PROs) (eg, activities-
specific balance confidence (ABC); and 12-item multiple sclerosis
walking scale (MSWS-12))(Bethoux and Bennett, 2011; Cohen et al.,
2015; Potter et al., 2014). Laboratory-based gait analysis, using markers
placed on the body as well as force plates, is the gold standard in
quantitative gait analysis (Bethoux and Bennett, 2011). However, in
clinical settings, several constraints including costs (eg, equipments),
space requirements (eg, room for a gait course), and time should be
considered when selecting the preferred tests as fall screening tools
(Bethoux and Bennett, 2011; Heesen et al., 2008). The results of a
multi-center study in patients with MS revealed that walking speed
obtained from a short test (i.e. T25FW), and walking distance obtained
from a longer test (i.e. 2MW test) are important PBMs for describing an
MS patient's general walking capacity (Gijbels et al., 2012). In addition,
PROs such as MSWS-12 and ABC, measure self-perceived functional
status while attempting various daily activities (Cohen et al., 2015;
Nilsagard et al., 2012). Moreover, different aspects such as fear of
falling and fatigue experienced during walking can be quantified by
PROs such as the fall efficacy scale international (FES-I) and the mod-
ified fatigue impact scale (MFIS) (Cohen et al., 2015; van Vliet et al.,
2013). These PROs may have added values because fatigue and fear of
falling can have adverse effects on patients’ performance, while they
cannot easily be quantified by simple functional tests.
The relative advantages of each approach have been debated in the
literatures (Bean et al., 2011; Beauchamp et al., 2015; Deshpande et al.,
2011). PBMs have been proposed to have better objectivity and are less
influenced by external factors while PROs offer low cost and con-
venience, and may represent a broader assessment of functions across
daily life (Beauchamp et al., 2015). A study by Cattaneo et al. showed
good discriminant validity of 2 PROs (ABC, dizziness handicap in-
ventory) to differentiate MS fallers from non-fallers, whereas the BBS,
TUG and hauser ambulation index tests were not able to differentiate
between the two groups (Cattaneo et al., 2006). In their study, retro-
spective falls during the month before the assessment procedure were
used to classify fallers and non-fallers (Cattaneo et al., 2006). However,
studies comparing the predictive validity of the two approaches with
respect to fall identification are scarce in patients with MS. Therefore,
the aim of this study was to prospectively analyze the predictive va-
lidity of some important PROs and PBMs to identify fall risk in a sample
of MS patients, who were ambulatory independent. For this purpose,
most commonly used PBMs including TUG, T25FW, cognitive T25FW,
2MW and cognitive 2MW were utilized in this study. In addition, a
series of valid and reliable PROs including MSWS-12, ABC, FES-I and
MFIS were administered. It was hypothesized that each individual test
could predict future falls in patients with MS and among the studied
variables, PROs would have greater ability to detect future falls than
PBMs. From a clinical point of view, identification of accurate fall
screening tools can assist therapists to determine the level of fall risk of
MS patients and this may help to promote future fall prevention in-
terventions.
2. Methods and materials
2.1. Participants
For this prospective cohort study, 90 patients with MS were re-
cruited from Khuzestan MS Patients’ Society. Inclusion criteria were as
follow: (1) a definite diagnosis of MS (of any subtype) diagnosed by a
neurologist; (2) an expanded disability status scale (EDSS, physician
version) of 0–5.5; and (3) no MS relapses 30 days prior to testing.
Patients were excluded under the following conditions: (1) self-reported
conditions other than MS known to affect balance and gait; (2) sever
cognitive impairments which impeded understanding instructions or
filling in the questionnaires; and (3) uncorrected visual impairments.
2.2. Procedures
Data were prospectively collected from August 2015 to February
2016. Each participant signed an inform consent form that had been
approved by the Internal Review Board of the University. Prior to data
collection, patients’ demographic information including disability
status, MS subtype, disease duration, age, gender, and body mass index
(BMI) were collected. The self-administered EDSS (EDSSS) ques-
tionnaire was used to record the disability status of the patients; and it
has been shown to be strongly correlated with the physician-adminis-
tered version (Bowen et al., 2001). For the main part of the data col-
lection process, patients were assessed by a physiotherapist with 5 years
of experience in clinical practice on the following PBMs: TUG, T25FW,
cognitive T25FW, 2MW, and cognitive 2 MW. In addition, patients were
asked to fill in the following PROs including ABC, MSWS-12, FES-I, and
MFIS. The order of administering PBMs and PROs was randomized. The
assessment was conducted in 1 session. A 2-min rest break was given to
the participants between each measure, with additional rest time pro-
vided if needed.
2.2.1. Predictor variables
2.2.1.1. PBMs. For the TUG test, which is a composite measure of
dynamic balance and mobility, participants were asked to stand up as
fast as possible from a seated position, walk out 3 m, turn around, and
return to the seated position. The score was the time taken to perform
the task. Each participant performed 3 trials of the TUG; then, the mean
of the 3 trials was calculated. The TUG has been shown to have a high
test-retest reliability in MS patients (intraclass correlation coefficient
[ICC] = 0.91) (Nilsagard et al., 2007).
For the T25FW test, which measures total mobility and leg perfor-
mance, participants were instructed to walk 25 feet as quickly as pos-
sible. The average duration of the 2 trials was calculated as the final
score. The T25FW has been shown to be a valid and reliable measure in
MS patients (Bethoux and Bennett, 2011; Cohen et al., 2015). The
cognitive T25FW test was used in this study to investigate whether dual
task interference, which is commonly seen in these patients, can con-
tribute to future falls (Hamilton et al., 2009). Thus, participants were
asked to perform aloud backward counting (serial 3 subtraction task),
while walking as fast as possible, then, the mean time required for the 2
trials was calculated. The dual task cost of performance was calculated
as follows: (single task- dual task) / (single task) ×100 (Etemadi,
2016).
For the 2MW test, which measures walking endurance, participants
were asked to walk for 2 min at their normal comfortable pace, then,
the distance walked during this time was measured. The 2MW test is a
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valid and reliable measure of gait performance in MS patients (Gijbels
et al., 2012, 2011). For the cognitive 2MW test, patients were asked to
perform aloud backward counting task, while walking for 2 min. The
dual task cost of performance was calculated as follows: (single task-
dual task)/(single task) ×100.
2.2.1.2. PROs. The ABC is a self-report measure of balance confidence
during activities of daily living (ADL). Participants rate their balance
confidence during 16 daily activities from 0 to 100, with 0 representing
no confidence and 100 indicating complete balance confidence in
performing these activities. The reliability of the ABC scale has been
shown to be high (test-retest reliability ICC = 0.92) in patients with MS
(Cattaneo et al., 2006; Nilsagard et al., 2012).
The MSWS-12 is a 12- item self-report measure of the impact of MS
on walking ability and is scored from 1 to 5, with 1 meaning no lim-
itation and 5 meaning extreme limitation of walking ability. The total
score ranges from 12 to 60, with higher scores indicating greater impact
of MS on gait performance, hence, greater disability. It is a reliable and
valid measure in patients with MS (Nakhostin Ansari et al., 2015).
In the present study, the FES-I was used to determine fear of falling.
It measures the level of concern about falling during ADL and contains
16 items, with 10 items assessing basic activities and 6 measuring more
demanding physical and social activities. Each item is scored on a scale
from 1 (not at all concerned) to 4 (very concerned), and the total score
ranges from 16 to 64, with higher scores indicating more concern about
falling. This scale is a valid instrument for assessing fear of falling in
patients with MS (van Vliet et al., 2013).
The MFIS was used as a measure of fatigue effects on ADL. It consists
of 21 items and the total score is the sum of the scores for the 21 items.
The Persian version of MFIS is a valid and reliable scale for assessing
fatigue in Iranian patients with MS (Ghajarzadeh et al., 2013).
2.3. Follow-up assessment of falls
Each participant's fall incidence was monitored prospectively for a
period of 6 months after initial testing. Participants were asked to re-
cord their falls each day for 6 months on fall calendars and return these
calendars at the end of each month. It was explained to the participants
that a fall is any unexpected event that results in ending up on the
ground, floor, or any lower surface (Coote et al., 2014). Based on the
previous studies, patients were classified as fallers if they had reported
one or more falls during the 6 months follow- up period (Coote et al.,
2014; Nilsagard et al., 2009).
2.4. Statistical analysis
For the main purpose of this study, the probability of any falls in the
following 6 months was modeled using logistic regression analysis.
First, univariate logistic regression was conducted to determine the
predictive ability of each variable separately, then multiple logistic
regression was conducted to investigate the predictive ability of the
studied variables in a model. Odds ratios (OR) and 95% confidence
intervals (CI) were calculated for each regression analysis. To allow
comparison of regression coefficients and ORs between variables with
different units, normalized values (z-scores) of the variables were used
for univariate regression analysis. In addition, a series of independent t-
tests were conducted to allow between group comparisons of fallers and
non-fallers on all outcome measures of this study. Moreover, to get
insight into the predictive accuracy of each variable, the area under the
receiver operating characteristic (ROC) curve (AUC) was computed for
each predictor. The ROC curve plots the true positive rate (predicted
falls that actually occurred) against the false positive rate (predicted
falls that did not actually occur). The AUC provides a summary measure
of accuracy in the prediction, ranging from 0.5 (chance) to 1.0 (perfect
accuracy).
To avoid the problem of multicollinearity (ie, intercorrelation
between predictor variables) for the subsequent multiple logistic re-
gression, principal component analysis (PCA) was conducted. PCA is a
method of transforming the original independent variables (predictors)
into new, uncorrelated variables. Extraction of variables was based on
eigenvalues> 1.0. Varimax normalization was used as the rotation
method. Then multiple logistic regression analysis, adjusted for clinical
and demographic variables (EDSSs, BMI, type of MS and gender), was
used to investigate the predictive ability of the factors extracted from
PCAs. All analyses were conducted using the IBM SPSS statistics soft-
ware (Version 22). Significance level was set at P<0.05.
3. Results
3.1. Participants and fall data
Prospective fall data were completed for 84 of the 90 included
participants; 2 patients were unwilling to participate in the follow- up,
1 withdrew for personal reasons, and 3 were excluded due to MS re-
lapses. With respect to prevalence of falling, 49% of participants (41
patients) reports 1 or more falls during the 6 months follow-up period
(12% of the MS participants reported 1 fall and 37% reported 2 or more
falls). Table 1 summarizes participants’ characteristics including clin-
ical and demographic data for the two patient groups (non-fallers and
fallers).
3.1.1. Prediction of falls in the following 6 months
The results of univariate logistic regression models revealed that all
variables, except the DTC of T25FW and 2MW tests, were significant
fall predictors (Table 2). The summary statistics for the PROs and PBMs
indicate worse performance by fallers in all 6 predictors (Table 3).
Fallers had significantly lower balance confidence, more self-perceived
gait difficulty, higher fatigue and fear of falling during daily activities in
comparison to non-fallers. In addition, reduced walking speed (T25FW
and TUG) and endurance (2MW) were observed at the time of assess-
ment in patients classified as fallers. The odds of falling was approxi-
mately 2.3 times greater, with one standard deviation (SD) decrease in
ABC than with one SD increase in MFIS (OR ABC = 0.060, 95% CI =
0.02–0.17; OR MFIS 7.32, 95% CI = 3.28–16.29). Among the studied
PBMs, the odds of falling was approximately 1.7 times greater with one
SD increase in T25FW test than with one SD increase in TUG test (OR
T25FW = 3.77, 95% CI = 1.86–7.63; OR TUG = 2.24, 95% CI =
1.17–4.27). The ROC curves and accompanying AUCs were statistically
significant for all 6 predictors. However, considering the AUCs, PROs
had better accuracy in predicting falls than PBMs. The ABC had the
highest AUC for fall prediction (AUC = 0.92), followed by the MSWS-
12 (AUC = 0.91) and FES-I (AUC= 0.89). The lowest AUC was for the
TUG (AUC = 0.65).
The results of PCA revealed that 2 PCs covered most of the variance
(83%). The first PC included FES, ABC, MFIS, and MSWS and accounted
for 46% of the variance. The second PC included 2 MW, TUG, and
Table 1
Demographic and clinical characteristics of non-faller and faller groups.
Characteristics Non- fallers Fallers P-value
Number of participants (%) 43 (51%) 41 (49%) NA
Age (yr) 33.80 (7.83) 30.29 (8.87) 0.8
Gender (Female/male) 36/7 26/15 <0.05
BMI (kg/m2) 26.46 (5.30) 23.45 (4.08) < 0.01
Disease duration (yr) 4.02 (4.15) 5.48 (5.19) 0.1
EDSSS 3.03 (1.29) 4.14 (1.00) < 0.01
Type of MS Relapsing-remitting 43 31 <0.01
Secondary progressive 0 7
Primary progressive 0 3
Note. Values are mean (standard deviation) or as otherwise indicated. EDSSS, Self-ad-
ministered expanded disability status scale. NA: not applicable.
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T25FW and increased the explained variance to 83% (Table 4). Fur-
thermore, the result of multiple logistic regression model with the first
two factors extracted from PCA and after adjusting for EDSS, BMI, type
of MS and gender variables revealed that both factors were significant
fall predictors with a greater OR for factor 1 (factor 1: P =<0.0001,
OR = 63.41 (6.72–597.90)) than factor 2 (P< 0.05, OR = 5.03
(1.33–18.99)) (Table 5). Model performance was further assessed using
the ROC curve. The AUC was 0.94 for the multiple regression model
indicating excellent overall accuracy.
4. Discussion
In the present study, we examined the predictive validity with re-
spect to fall incidence of a series of lower extremity PBMs (TUG,
T25FW, DTC T25FW, 2MW and DTC 2MW) and PROs (ABC, MSWS-12,
FES-I, MFIS) in a sample of MS patients who were ambulatory in-
dependent. The results of logistic regression analysis revealed that most
of the studied variables except DTC of walking tests were significant fall
predictors. Specifically, fallers had lower balance confidence, more self-
perceived walking difficulty, fatigue, and fear of falling during daily
activities. Moreover, reduced walking speed (T25FW&TUG) and en-
durance (2MW) were observed at the time of assessment in patients
classified as fallers. However, considering the AUC of individual vari-
able and the result of multiple logistic regression, it seems that PROs
may offer more values as predictors of future falls. These results provide
preliminary guidance for the use of these measures in the clinics to
identify potential fallers and in trials regarding the efficacy of fall-
prevention interventions.
While extensive evidences support the construct validity of the
studied variables in patients with MS (Cattaneo et al., 2006;
Ghajarzadeh et al., 2013; Nakhostin Ansari et al., 2015; van Vliet et al.,
2013), little is known about the predictive validity of these instruments
with respect to fall identification. As hypothesized, the result of mul-
tiple logistic regression showed that after adjusting for clinical and
demographic variables (disability level, type of disease, sex and BMI),
both factor 1 (PROs) and factor 2 (PBMs) were significant fall predictors
with a greater OR for factor 1 than factor 2. Moreover, in terms of
relative accuracy of predicting falls, all of the clinical tests and scales
had AUC values greater than those associated with random assignment
(50%); however, the TUG test possessed the lowest AUC (0.65) and the
ABC had the highest AUC (0.92) value. Such findings suggest that the
presence of mobility-related impairments particularly walking impair-
ments contribute to the increased risk of falling in patients with MS.
Previously, Cameron et al. investigated the ability of some instruments
(fall history, ABC, MSWS-12, FES-I, and T25FW) to predict falls in pa-
tients with MS (Cameron et al., 2013). They reported that simply asking
patients about their fall history had the greatest accuracy in predicting
future falls, followed by T25FW and ABC. However, the AUCs of the
above-mentioned variables ranged from 0.69 to 0.75, which may not
Table 2
Univariate logistic regression analysis with fall incidence (no fall versus ≥ 1 fall) as the dependent variable.
Predictors AUC B SE Wald df p-value Odds ratio
(95% confidence interval)
ABC 0.92 −2.815 0.550 26.194 1 <0.0001 0.060 (0.020.−0.176)
MSWS-12 0.91 2.473 0.484 26.119 1 <0.0001 11.853 (4.592–30.593)
FES-I 0.89 2.227 0.439 25.794 1 <0.0001 9.273 (3.926–21.902)
MFIS 0.87 1.991 0.408 23.787 1 <0.0001 7.320 (3.289–16.290)
T25FW 0.79 1.327 0.360 0.595 1 <0.0001 3.770 (1.862–7.633)
2MW 0.71 −0.823 0.272 9.180 1 0.002 0.439 (0.258–0.748)
TUG 0.65 0.807 0.330 5.980 1 0.014 2.241 (1.174–4.278)
DTC 2MW 0.49 0.102 0.221 0.212 1 0.645 1.107 (0.718–1.706)
DTC T25FW 0.48 −0.015 0.220 0.005 1 0.945 0.985 (0.641–1.515)
ABC: activities- specific balance confidence, FES-I: fall efficacy scale international, MSWS-12: 12-item multiple sclerosis walking scale, MFIS: modified fatigue-impact scale, T25FW: timed
25 foot walk test, 2MW: 2-min walk, TUG: timed up and go, DTC: dual task cost, AUC: area under the curve, B: regression coefficient; SE: standard error; df: degrees of freedom; OR: odds
ratio; CI: confidence interval.
Table 3









ABC 49.04 (18.12) 85.64 (12.18) <0.01
MSWS-12 44.65 (17.71) 12.42 (11.95) <0.01
FES-I 41.63 (10.79) 23.79 (7.00) <0.01
MFIS 53.82 (20.00) 23.55 (14.30) <0.01
T25FW 5.87 (1.14) 4.88 (0.72) <0.01
2MW 122.43 (24.80) 139.51 (20.40) <0.01
TUG 8.61 (2.47) 7.48 (1.13) <0.01
DTC 2MW 14.88 (16.21) 13.43 (12.82) 0.65
DTC T25FW −26.25 (37.74) −25.69 (37.09) 0.94
ABC: activities- specific balance confidence, FES-I: fall efficacy scale international, MSWS-
12: 12-item multiple sclerosis walking scale, MFIS: modified fatigue-impact scale, T25FW:
timed 25 foot walk test, 2MW: 2-min walk, TUG: timed up and go, DTC: dual task cost.
Table 4
Principal component analysis (PCA), factor loadings of the first 2 PCs.








FES-I: fall efficacy scale international, ABC: activities- specific balance confidence, MFIS:
modified fatigue impact scale, MSWS-12: 12-item multiple sclerosis walking scale, 2MW:
2 min walk, TUG: timed up and go, T25FW: timed 25 foot walk test.
Table 5
Multivariate logistic regression with fall incidence (no fall versus ≥ 1 fall) as the de-
pendent variable.




4.150 1.145 13.140 1 <0.0001 63.414 (6.726–597.900)
Factor 2
(PBMs)
1.617 0.677 5.703 1 <0.05 5.038 (1.336–18.992)
Adjusted for BMI, gender, EDSSS and type of disease. Factor 1 & 2 were extracted form
principal component analysis.
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warrant their use in isolation (Cameron et al., 2013). Similarly in an-
other prospective study of fall risk factors in patients with MS, the ABC
scale was able to distinguish between fallers and non-fallers and had
acceptable predictive accuracy level while TUG test was not able to
predict future falls (Dibble et al., 2013). Smaller sample size of the
above mentioned studies in comparison to our study, heterogeneity in
the definition of fallers and different duration of follow-up may have
accounted for the different results of AUCs. Future studies shall follow
recommendations made by the international MS falls prevention re-
search network regarding the definitions of falls, fallers and methods of
measuring falls to allow valid comparisons between results of different
studies (Coote et al., 2014).
We expected higher predictive validity of the PROs in comparison to
PBMs. There are several possible explanations for such finding. One
explanation is that PROs such as the ABC and MSWS-12 reflect an in-
dividual's perception of ability across a broad range of activities in re-
levant contexts while PBMs reflect performance of isolated activities
without a functional context (Bean et al., 2011; Beauchamp et al.,
2015). In addition, most commonly used PBMs such as TUG, T25FW
and 2MW assess performance of one dimension of impaired mobility
such as reduced gait speed or endurance while most patient-reported
questionnaires (eg, ABC, FES-I, MFIS) assess different dimensions of
mobility as well as psychological aspects of impaired mobility (Landers
et al., 2016). Similar findings have been found in other populations
prone to falling such as elderly and patients with stroke (Bean et al.,
2011; Beauchamp et al., 2015; Beninato et al., 2009). For instance, it
has been shown that in patients with stroke, the ABC Scale (AUC =
0.92) and the stroke impact scale (AUC = 0.86) had stronger associa-
tions with falls than the BBS (AUC= 0.76) and sit to stand task (AUC=
0.66) (Beninato et al., 2009). Taken together these findings, it seems
that clinical measures of more-global states of physical functioning such
as the studied PROs, are potentially useful fall screening tools and need
to be further examined in MS population.
Among the PBMs used in this study, cognitive-motor interference as
measured by DTC of walking tests, was not predictive of future falls in
patients with MS. The rationale for investigating DTC was the high
prevalence of cognitive impairments in MS patients, which may inter-
fere with functions and increase the risk of falling (Gianni et al., 2014;
Gunn et al., 2013b; Kalron, 2014). However, our results revealed that
DTC of walking tests failed to predict future falls. The effects of specific
cognitive deficits on risk of falls in MS patients have previously been
explored (Kalron, 2014). Moreover, various studies have shown that
dual tasking effects are greater among the MS population compared
with healthy individuals (Hamilton et al., 2009; Negahban et al., 2011),
nonetheless, the evidence on its association with future falls is still
controversial (Etemadi, 2016; Wajda et al., 2013; Wajda and Sosnoff,
2015). In a recent study by Etemadi et al., it was found that DTC of
walking speed was predictive of future falls in MS patients (Etemadi,
2016). However, in their study, walking speed was assessed using an
electronic walkway, moreover, complexity of the cognitive task was
higher than our study (serial 7 subtraction)(Etemadi, 2016). Therefore,
further studies with more complex tests are needed to examine the
relationship between cognitive-motor interference and falls in MS pa-
tients.
Although this study provided insight into fall risk screening tools,
several limitations need to be considered. The study sample was re-
stricted to patients with MS, who were ambulatory independent and
had mild to moderate disability. Thus, generalizability of the results is
restricted to this subgroup of ambulatory active patients. In addition,
the predictor variables used in the present study cannot directly inform
choices about the content of fall prevention and management protocols,
however, they are clinically applicable as fall risk screening tools.
Future studies with larger sample size are required to include a more
heterogeneous sample of patients.
5. Conclusion
In conclusion, for the purpose of fall screening among patients with
MS, PROs and PBMs of this study seem to be able to predict future falls
in patients with MS. However, PROs including ABC, MSWS-12, FES-I
and MFIS were more accurate in identifying patients at high risk of
falling than commonly used PBMs such as T25FW, TUG and 2MW. The
results of this study provide preliminary guidance for the use of these
measures in the clinics to identify potential fallers and in trials re-
garding the efficacy of fall-prevention interventions.
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